IGFBP-1 Expression Promotes Tamoxifen Resistance in Breast Cancer Cells via Erk Pathway ActivationZheng Yan, Kevin D. Houston|Frontiers in Endocrinology|2020Cited by 29
Glucose-dependent GPER1 expression modulates tamoxifen-induced IGFBP-1 accumulationZheng Yan, Kevin D. Houston|Journal of Molecular Endocrinology|2019Cited by 9
Insulin-like growth factor binding protein-6 modulates proliferative antagonism in response to progesterone in breast cancerFrancisco Javier Lariz, Kevin D. Houston|Frontiers in Endocrinology|2024Cited by 1
Insulin-like growth factor-binding protein-3 is induced by tamoxifen and fulvestrant and modulates fulvestrant response in breast cancer cellsKeenan L. Flynn, Kevin D. Houston|Frontiers in Oncology|2024Cited by 0
IGFBP-6 regulates breast cancer cell cycle progression by promoting exit out of G1Francisco Javier Lariz, Kevin D. Houston|Journal of Biological Chemistry|2025Cited by 0